Clinical Trial Update: Statin Impact on Hepatic Decompensation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating the impact of statins on hepatic decompensation and quality of life has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Decompensation
• Liver Cirrhosis
• Liver Disease

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Tanta University | Conditions: Quality of Life | Phase 2, Phase 3 | Status: COMPLETED